Pages that link to "Q33275412"

The following pages link to PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (Q33275412):

Displaying 24 items.

• Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma (Q33275611) (← links)
• Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab (Q33276035) (← links)
• Immunotherapy as a Potential Treatment for Chordoma: a Review (Q33276143) (← links)
• Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis (Q33276164) (← links)
• Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma (Q33276468) (← links)
• Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. (Q39003387) (← links)
• Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma (Q40582859) (← links)
• A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition (Q42150466) (← links)
• Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer (Q42260320) (← links)
• Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape (Q46129475) (← links)
• Chordoma: The Quest for Better Treatment Options. (Q51034581) (← links)
• Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment. (Q51339102) (← links)
• First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies. (Q53068022) (← links)
• Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection. (Q55406159) (← links)
• Advances in immune checkpoint inhibitors for bone sarcoma therapy (Q61807295) (← links)
• Defective homologous recombination DNA repair as therapeutic target in advanced chordoma (Q63071454) (← links)
• Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer (Q64226395) (← links)
• Fingolimod inhibits proliferation and epithelial-mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling (Q89572810) (← links)
• New Prospects for Molecular Targets for Chordomas (Q90136748) (← links)
• Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors (Q91012629) (← links)
• Chordoma: A Case Report and Review of Literature (Q92859956) (← links)
• A four-factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma (Q96167187) (← links)
• Translational Windows in Chordoma: A Target Appraisal (Q98177563) (← links)
• Analysis of Mutational Signatures with YAPSA (Yet Another Package for Signature Analysis) (Q102321369) (← links)